DESMOPLASTIC SMALL ROUND CELL TUMOUR

This adverse event was reported 87 times

DESMOPLASTIC SMALL ROUND CELL TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOPOTECAN 40 0.0065
1 DACTINOMYCIN 12 0.0054
2 VINORELBINE 33 0.0047
3 LAROTRECTINIB 3 0.0033
4 TRABECTEDIN 7 0.0030
5 TEMOZOLOMIDE 47 0.0022
6 IFOSFAMIDE FOR INJECTION 41 0.0019
7 PAZOPANIB HYDROCHLORIDE 48 0.0018
8 IRINOTECAN HYDROCHLORIDE 21 0.0016
9 GEMCITABINE HYDROCHLORIDE 38 0.0007
See all drugs enriched for association with DESMOPLASTIC SMALL ROUND CELL TUMOUR

DESMOPLASTIC SMALL ROUND CELL TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 12 0.0054
1 Topoisomerase Inhibitor [EPC] 49 0.0006
2 Alkylating Drug [EPC] 62 0.0003
3 Serotonin-3 Receptor Antagonist [EPC] 31 0.0002
4 Microtubule Inhibitor [EPC] 37 0.0002
5 Kinase Inhibitor [EPC] 42 0.0001
6 Influenza A M2 Protein Inhibitor [EPC] 1 0.0001
7 Antimetabolite Immunosuppressant [EPC] 1 0.0000
8 Platinum-based Drug [EPC] 11 0.0000
9 Leukocyte Growth Factor [EPC] 5 0.0000
See all drug classes enriched for association with DESMOPLASTIC SMALL ROUND CELL TUMOUR